Research progress of neural stem cell transplantation in the treatment of severe cerebral palsy in child Reviewer: ZHOU Juhua, FANG Suzhen, ZHOU Xizhong, Reviser: LI Hong (Department of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China)
[1] Dabney KW,Miller F. Current approaches in cerebral palsy,a focus on gait problems: editorial comment [J]. Clin Orthop Relat Res,2012,470(5):1247-1248. [2] 沈晓明,王卫平. 儿科学 [M]. 7版. 北京:人民卫生出版社,2008:373. [3] Luan Z,Liu W,Qu S,et al. Effects of neural progenitor cell transplantation in children with severe cerebral palsy [J]. Cell Transplant,2012,21(Suppl1):S91-S98. [4] Blair E. Epidemiology of the cerebral palsies [J]. Orthop Clin North Am,2010,41(4):441-455. [5] Zheng XR,Zhang SS,Yin F,et al. Neuroprotection of VEGF-expression neural stem cells in neonatal cerebral palsy rats [J]. Behav Brain Res,2012,230(1):108-115. [6] Azari H,Rahman M,Sharififar S,et al. Isolation and expansion of the adult mouse neural stem cells using the neurosphere assay [J]. J Vis Exp,2010,(45):2393. [7] Deleyrolle LP,Reynolds BA. Isolation,expansion,and differentiation of adult Mammalian neural stem and progenitor cells using the neurosphere assay [J]. Methods Mol Biol,2009,549:91-101. [8] Azari H,Osborne GW,Yasuda T,et al. Purification of immature neuronal cells from neural stem cell progeny [J]. PLoS One,2011,6(6):e20941. [9] Goldman SA,Windrem MS. Cell replacement therapy in neurological disease [J]. Philos Trans R Soc Lond B Biol Sci,2006,361(1473):1463-1475. [10] Louis SA,Mak CK,Reynolds BA. Methods to culture,differentiate,and characterize neural stem cells from the adult and embryonic mouse central nervous system [J]. Methods Mol Biol,2013,946:479-506. [11] Xu N,Papagiannakopoulos T,Pan G,et al. MicroRNA-145 regulates OCT4,SOX2,and KLF4 and represses pluripotency in human embryonic stem cells [J]. Cell,2009,137(4):647-658. [12] Yue F,Chen B,Wu D,et al. Biological properties of neural progenitor cells isolated from the hippocampus of adult cynomolgus monkeys [J]. Chin Med J (Engl),2006,119(2):110-116. [13] Fansa H,Keilhoff G. Comparison of different biogenic matrices see-ded with cultured Schwann cells for bridging peripheral nerve defects[J]. Neurol Res,2004,26(2):167-173. [14] Bliss T,Guzman R,Daadi M,et al. Cell transplantation therapy for stroke [J]. Stroke,2007,38(Suppl 2):817-826. [15] Rosenblum S,Wang N,Smith TN,et al. Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment,survival,and differentiation [J]. Stroke,2012,43(6): 1624-1631. [16] Daadi MM,Davis AS,Arac A,et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury [J]. Stroke,2010,41(3):516-523. [17] Madhavan L,Ourednik V,Ourednik J. Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression [J]. Stem Cells,2008,26(1):254-265. [18] Tongiorgi E. Activity-dependent expression of brain-derived neurotrophic factor in dendrites:facts and open questions [J]. Neurosci Res,2008,61(4):335-346. [19] Lee JS,Hong JM,Moon GJ,et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke [J]. Stem Cells,2010,28(6):1099-1106. [20] Li Y,Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury [J]. Neurosci Lett,2009,456(3):120-123. [21] Chen J,Zhang ZG,Li Y,et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats [J]. Circ Res,2003,92(6): 692-699. [22] Amit M,Chebath J,Margulets V,et al. Suspension culture of undiffe-rentiated human embryonic and induced pluripotent stem cells [J]. Stem Cell Rev,2010,6(2):248-259. [23] McDonald JW,Liu XZ,Qu Y,et al. Transplanted embryonic stem cells survive,differentiate and promote recovery in injured rat spinal cord [J]. Nat Med,1999,5(12):1410-1412. [24] van Velthoven CT,Kavelaars A,van Bel F,et al. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage [J]. Pediatr Res,2010,68(5):419-422. [25] Webber DJ,van Blitterswijk M,Chandran S. Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia [J]. Am J Pathol,2009,175(6): 2332-2342. [26] 栾佐,屈素清,刘卫鹏,等. 人神经干细胞移植治疗重度视觉障碍脑瘫患儿的临床观察 [J]. 中国康复理论与实践,2007,13(12):1103-1105. [27] Chandran S,Caldwell M,Allen N. Introduction: stem cells and brain repair [J]. Philos Trans R Soc Lond B Biol Sci,2008,363(1489):5-7. [28] Kim S,Honmou O,Kato K,et al. Neural differentiation potential of peripheral blood and bone marrow-derived precursor cells [J]. Brain Res,2006,1123(1):27-33. [29] Wei L,Fraser JL,Lu ZY,et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats [J]. Neurobiol Dis,2012,46(3):635-645. [30] Li M,Yu A,Zhang F,et al. Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells [J]. J Transl Med,2012,10:100. [31] Purandare C,Shitole DG,Belle V,et al. Therapeutic potential of auto-logous stem cell transplantation for cerebral palsy [J]. Case Rep Transplant,2012,2012:825289. [32] Lu D,Chen B,Liang Z,et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind,randomized,controlled trial [J]. Diabetes Res Clin Pract,2011,92(1):26-36. [33] 杜侃,栾佐,屈素清,等. 骨髓间充质干细胞移植治疗小儿重度脑性瘫痪的疗效观察 [J]. 临床儿科杂志,2011,29(1):55-58. [34] Sun J,Allison J,McLaughlin C,et al. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders [J]. Transfusion,2010,50(9):1980-1987. [35] Lee YH,Choi KV,Moon JH,et al. Safety and feasibility of counte-ring neurological impairment by intravenous administration of autologous cord blood in cerebral palsy [J]. J Transl Med,2012,10: 58. [36] 杨华强,张荣环,杜玲,等. 脐带间充质干细胞移植对脑瘫患儿运动功能的影响 [J]. 现代生物医学进展,2012,12(2):250-252. [37] Jensen A,Hamelmann E. First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest-individual treatment with cord blood [J]. Case Rep Transplant,2013,2013: 951827. [38] International Association of Neurorestoratology. Beijing Declaration of International Association of Neurorestoratology (IANR). Cell Transplant,2009,18:487. [39] Tian ZM,Chen T,Zhong N,et al. Clinical study of transplantation of neural stem cells in therapy of inherited cerebellar atrophy [J]. Beijing Da Xue Xue Bao,2009,41(4):456-458. [40] 吴景文,贾丹兵,曲超法,等. 干细胞移植治疗小儿脑瘫的临床疗效:40例报告 [J]. 中华神经外科疾病研究杂志,2011,10(5): 424-427. [41] Shimazu K,Zhao M,Sakata K,et al. NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis [J].Learn Mem,2006,13(3):307-315. [42] Wang LM,Wang HY,Yang ZJ,et al. Combined transplantation of neurotrophin-3 and neural stem cells in treatment of hypoxic-ischemic brain injury in rats[J]. Zhonghua Er Ke Za Zhi,2007,45(3): 212-216. [43] 栾 佐.新生动物及其缺血性脑损伤神经干细胞移植的研究现状[J].中华儿科杂志,2004,42(4):305-307. (收稿日期:2013-07-01)